Tag: Cancer: Misc.

Risk reduced for gastrointestinal cancers, increased for cancers of neurological origin

Increase also seen in prevalence of multiple chronic conditions for cancer survivors, which was most pronounced among those aged 18 to 44 years

Program aims to reduce cancer death rate by 50 percent during the next 25 years

Incidences of major adverse cardiovascular events, cancers higher with tofacitinib versus TNF inhibitor; criteria for noninferiority not met

Mortality rate increases with increasing sequential organ failure assessment score on admission, respiratory failure, maximum lactate level

Overall survival, progression-free survival prolonged in those receiving durvalumab versus placebo in addition to gemcitabine and cisplatin

Standardized incidence ratio was 3.0 during first year of follow-up after VTE and decreased to 1.5 during subsequent years

51 percent of institutions cite decreased clinical staff availability; HCPs experiencing psychological distress, financial concerns

Guideline-nonconcordant radiotherapy given to substantial proportion of Medicare beneficiaries with metastatic cancer near the end of life

The NCCN Advisory Committee supports the strong preference for mRNA vaccines and offers guidance on the timing of vaccination